Use of postmenopausal hormone replacement therapy: estimates from a nationally representative cohort study
- PMID: 9063344
- DOI: 10.1093/oxfordjournals.aje.a009142
Use of postmenopausal hormone replacement therapy: estimates from a nationally representative cohort study
Abstract
The objective of this study was to describe trends in the use of hormone replacement therapy (HRT) in the United States by demographic, life-style, and heart disease risk factors. Data were obtained from the Epidemiologic Followup Study to the First National Health and Nutrition Examination Survey, a nationally representative cohort followed from the mid-1970s until 1992. A total of 5,602 women who had become menopausal by their last follow-up interview were included. An estimated 45% of the cohort of menopausal US women 25-74 years of age in the early 1970s used HRT for at least one month and 20% continued use for 5 or more years. Between 1987 and 1992, as the younger members of the cohort became menopausal, the proportion of this cohort who had ever used HRT and used it for 5 or more years increased by 32% and 54%, respectively. A higher probability of HRT use was found among women who were white, who were more highly educated, and who lived in the West, or who had experienced a surgical menopause. Women who were overweight or who abstained from alcohol were less likely to use HRT. These data support the hypothesis that HRT use is associated with sociodemographic factors, and that women tend to discontinue use within several years.
Similar articles
-
Life prevalence and determinants of hormone replacement therapy in women living in Porto, Portugal.Maturitas. 2007 Jul 20;57(3):226-32. doi: 10.1016/j.maturitas.2006.12.005. Epub 2007 Feb 12. Maturitas. 2007. PMID: 17293067
-
Hormone replacement and menopausal symptoms following hysterectomy.Am J Epidemiol. 1997 Nov 15;146(10):870-80. doi: 10.1093/oxfordjournals.aje.a009204. Am J Epidemiol. 1997. PMID: 9384207
-
Prevalence and characteristics associated with use of hormone replacement therapy in Britain.Br J Obstet Gynaecol. 1997 Mar;104(3):290-7. doi: 10.1111/j.1471-0528.1997.tb11456.x. Br J Obstet Gynaecol. 1997. PMID: 9091004
-
Hormone replacement therapy in the aged. A state of the art review.Drugs Aging. 1996 Mar;8(3):193-213. doi: 10.2165/00002512-199608030-00005. Drugs Aging. 1996. PMID: 8720745 Review.
-
Comparative cardiovascular effects of different progestins in menopause.Int J Fertil Womens Med. 2001 Sep-Oct;46(5):248-56. Int J Fertil Womens Med. 2001. PMID: 11720197 Review.
Cited by
-
Health status of users of hormone replacement therapy by hysterectomy status in Western Australia.J Epidemiol Community Health. 2003 Apr;57(4):294-300. doi: 10.1136/jech.57.4.294. J Epidemiol Community Health. 2003. PMID: 12646547 Free PMC article.
-
Hormone replacement therapy is safe in women undergoing coronary artery bypass grafting.Tex Heart Inst J. 2005;32(4):507-14. Tex Heart Inst J. 2005. PMID: 16429894 Free PMC article.
-
Use of hormone replacement therapy among Danish nurses at increased risk of osteoporosis.Int J Behav Med. 2003;10(3):269-83. doi: 10.1207/s15327558ijbm1003_06. Int J Behav Med. 2003. PMID: 14525721
-
Menopausal hormones and breast cancer in a biracial population.Am J Public Health. 2000 Jun;90(6):966-71. doi: 10.2105/ajph.90.6.966. Am J Public Health. 2000. PMID: 10846517 Free PMC article.
-
Estrogen-related genes and their contribution to racial differences in breast cancer risk.Cancer Causes Control. 2012 May;23(5):671-81. doi: 10.1007/s10552-012-9925-x. Epub 2012 Mar 15. Cancer Causes Control. 2012. PMID: 22418777 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources